Because the ML analyses to this point have focused on gene signatures previously implicated in lupus (17, 21, 22), with less emphasis on those implicated in other inflammatory skin diseases (23, 24), we also examined enrichment of previously published PSO- or AD-specific gene signatures in the four lesional inflammatory skin diseases as compared to healthy controls. This evidence concerns the gene PIPOX and systemic lupus erythematosus.